[ad_1]
“The news about the reduction of AstraZeneca’s vaccine supply to Lithuania in the first quarter of this year does not change the goal of vaccinating 2 million people and obtaining herd immunity by midsummer.” This goal is based on the supply plans of several vaccines, so changing information about the supply of one of them does not change the substance, “said the country’s chief in a comment to BNS on Saturday.
He reiterated that to vaccinate 70%. adults in July, in the second trimester Lithuania should be ready to vaccinate an average of 34-35 thousand. people a day.
“There will be many more challenges for vaccine supply, so we must work in a distracted, intensive, consistent and coordinated manner at the national and municipal levels. We must ensure the possibility of vaccinating a critical number of the Lithuanian population in mid-summer, “said G. Nausėda.
The Lithuanian Ministry of Health claims that UK-based pharmaceutical company AstraZeneca has reported that it will supply only a fifth of the number of vaccines planned for Lithuania in the first quarter of this year. The exact number of vaccines is not published. The company’s vaccine is being used in the UK, but has not yet been approved in the European Union, with a decision expected by the end of January.
AstraZeneca warned on Friday that development of its coronavirus vaccine in Europe would be “less than initially expected” due to reduced production capacity.
Earlier, Pfizer, a company that already supplies vaccines to Europe, announced that the pace of vaccine supply will slow in the coming weeks due to work to be done at its parent company in Belgium.
The BioNTech and Pfizer and Moderna vaccines are currently being vaccinated in Lithuania.
[ad_2]
